BA
FOLD

BlackRock Advisors’s Amicus Therapeutics FOLD Stock Holding History

BlackRock Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$414K Sell
83,321
-45,192
-35% -$313K ﹤0.01% 2308
2016
Q3 		$951K Buy
128,513
+40,311
+46% +$272K ﹤0.01% 1849
2016
Q2 		$482K Buy
88,202
+5,147
+6% +$36K ﹤0.01% 2138
2016
Q1 		$702K Sell
83,055
-20,509
-20% -$145K ﹤0.01% 1919
2015
Q4 		$1M Sell
103,564
-46,259
-31% -$417K ﹤0.01% 1707
2015
Q3 		$2.1M Sell
149,823
-4,758
-3% -$74.6K ﹤0.01% 1346
2015
Q2 		$2.19M Sell
154,581
-8,328
-5% -$100K ﹤0.01% 1235
2015
Q1 		$1.77M Sell
162,909
-61,010
-27% -$538K ﹤0.01% 1275
2014
Q4 		$1.86M Buy
223,919
+971
+0.4% +$6.66K ﹤0.01% 1224
2014
Q3 		$1.33M Buy
222,948
+210,320
+1,666% +$1.1M ﹤0.01% 1309
2014
Q2 		$42K Sell
12,628
-16,599
-57% -$39K ﹤0.01% 3285
2014
Q1 		$60K Buy
29,227
+3,964
+16% +$9.91K ﹤0.01% 3206
2013
Q4 		$59K Buy
25,263
+3,976
+19% +$8.73K ﹤0.01% 3204
2013
Q3 		$49K Buy
21,287
+561
+3% +$1.41K ﹤0.01% 3190
2013
Q2 		$48K Buy
+20,726
New +$63.7K ﹤0.01% 3174

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Advisors's FOLD Position: Q4 2016 in Review

BlackRock Advisors reduced its Amicus Therapeutics (FOLD) stake by 35% in Q4 2016, selling an estimated $313K and leaving 83,321 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

BlackRock Advisors first reported a position in FOLD in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.19M in Q2 2015. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • BlackRock Advisors held 83,321 shares of Amicus Therapeutics worth $414K as of Q4 2016.
  • BlackRock Advisors sold 45,192 Amicus Therapeutics shares in Q4 2016, an estimated $313K.
  • Amicus Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2308 holding.
  • BlackRock Advisors first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Amicus Therapeutics position peaked at $2.19M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.